Oxidative metabolism of anandamide

Prostaglandins and Other Lipid Mediators

Volumn 61, Issue 1-2, 2000, Pages 29-41

  Burstein, Sumner H ^a,b   Rossetti, Ronald G ^b   Yagen, Boris ^a   Zurier, Robert B ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Psychiat Dept Univ M   (United States)

Author keywords

Anandamide; Cyclooxygenase; Hepatocytes; Macrophages; Metabolism

Indexed keywords

ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYLGLYCINE; LIPOXYGENASE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; BIOSYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; ISOTOPE LABELING; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; REACTION ANALYSIS; REVIEW;

EID: 0034002087     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(00)00053-8     Document Type: Article

References (33)

1. Axelrod J., Felder C.C. Cannabinoid receptors and their endogenous agonist, anandamide. Neurochem Res. 23:1998;575-581.
2. Di Marzo V. Biosynthesis and inactivation of endocannabinoids relevance to their proposed role as neuromodulators . Life Sci. 65:1999;645-655.
3. Hillard C.J., Campbell W.B. Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. J Lipid Res. 38:1997;2383-2398.
4. Zimmer A., Zimmer A.M., Hohmann Herkenham M., Bonner T. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci. 96:1999;5780-5785.
5. Kruska K.K., Gross R.W. The ATP- and CoA-independent synthesis of arachidonoylethanolamide. J Biol Chem. 269:1994;14345-14348.
6. Burstein S.H., Hunter S.A. Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by THC. Biochem Pharmacol. 49:1995;855-858.
7. Burstein S., Budrow J., Debatis M., Hunter S.A., Subramanian A. Phospholipase participation in cannabinoid-induced release of free arachidonic acid. Biochem Pharmacol. 48:1994;1253-1264.
8. Ueda N., Kurahashi Y., Yamamoto S., Tokunaga T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J Biol Chem. 270:1995;23823-23827.
9. Devane W.A., Axelrod J. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc Natl Acad Sci USA. 91:1994;6698-6701.
10. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
11. Bisogno T., Maurelli S., Melck D., De Petrocellis L., Di Marzo V. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem. 272:1997;3315-3323.
12. Di Marzo V., De Petrocellis L., Sepe N., Buono A. Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem J. 316:1996;977-984.
13. Hansen H.S., Lauritzen L., Moesgaard B., Strand A.M., Hansen H.H. Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines proposed role in neurotoxicity . Biochem Pharmacol. 55:1998;719-725.
14. Schmid P.C., Kuwae T., Krebsbach R.J., Schmid H.H. Anandamide and other N-acylethanolamines in mouse peritoneal macrophages. Chem Phys Lipids. 87:1997;103-110.
15. Deutsch D.G., Chin S.A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol. 46:(5):1993;791-796.
16. Giang D.K., Cravatt B.F. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci. 94:1997;2238-2242.
17. Ueda N., Yamamoto K., Yamamoto S., Tokunaga T., Shirakawa E., Shinaki H., Ogawa M., Sato T., Kudo I., Inoue K., Takizawa H., Nagano T., Hirobe M., Saito H. Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. Biochem Biophys Acta. 1254:1995;127-134.
18. Hampson A.J., Hill W.A., Zan-Phillips M., Makriyannis A., Leung E., Eglen R.M., Bornheim L.M. Anandamide hydroxylation by brain lipoxygenase metabolite structures and potencies at the cannabinoid receptor . Biochem Biophys Acta. 1259:1995;173-179.
19. Edgemond W.S., Hillard C.J., Falck J.R., Kearn C.S., Campbell W.B. Human platelets and polymorphonuclear leukocytes synthesize derivatives of anandamide their affinities for cannabinoid receptors and pathways of inactivation . Mol Pharmacol. 54:1998;180-188.
20. Yu M., Ives D., Ramesha C.S. Synthesis of PGE2 ethanolamide from anandamide by COX-2. J Biol Chem. 272:1997;21181-21186.
21. So O-Y, Scarafia LE, Mak AY, Callan OH, Swinney DCJ. Biol Chem 1998;273:5801-7.
22. Herschman H. Prostaglandin synthase-2. Biochim Biophys Acta. 1299:1996;125-140.
23. Willoughby K.A., Moore S.F., Martin B.R., Ellis E.F. The biodisposition and metabolism of anandamide in mice. J Pharm Exp Ther. 282:1997;243-247.
24. Bornheim L.M., Kim K.Y., Chen B., Correia M.A. The effect of cannabidiol on mouse hepatic microsomal cytochrome p-450 dependent anandamide metabolism. Biochem Biophys Res Comm. 197:1993;740-746.
25. Bornheim L.M., Kim K.Y., Chen B., Correia M.A. Microsomal cytochrome p-450 mediated liver and brain anandamide metabolism. Biochem Pharmacol. 50:1995;677-686.
26. Merkler D.J., Merkler K.A., Stern W., Fleming F.F. Fatty acid amide biosynthesis a possible new role for peptidylglycine a-amidating enzyme and acyl-CoA: glycine N-acyl transferase . Arch Biochem Biophys. 330:1996;430-434.
27. Wilcox BJ, Ritenour-Rogers J, Asser AS, Baumgart LE, Baumgart ME, Boger DL, DeBlassio JL, deLong MA, Glufke U, Henz ME, King L III, Merkler KA, Patterson JE, Robelski JJ, Vederas JC, Merkler DJ. N-acyl glycine amidation: implications for the biosynthesis of fatty acid primary amides.
28. Martinez A., Treston A.M. Where does amidation take place? Mol Cell Endocr. 123:1996;113-117.
29. Burstein S, Monaghan A, Pearson W, Rooney T, Yagen B, Zipkin R, Zurier A. Studies with analogs of anandamide and indomethacin. Proc ICRS 1997;XX:31.
30. Burstein S.H. The cannabinoid acids nonpsychoactive derivatives with therapeutic potential . Pharmacol Therap. 82:1999;87-96.
31. Pestonjamasp V.K., Burstein S.H. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochem Biophys Acta. 1394:1998;249-260.
32. Goto M., Fujisawa M., Yamada A., Okabe T., Takau F., Sasano M., Nishioka K. Spontaneous release of angiotensin converting enzyme and interleukin 1-b from peripheral blood monocytes from patients with rheumatoid arthritis under serum free conditions. Ann Rheum Dis. 49:1990;172-176.
33. Burstein S.H., Audette C.A., Breuer A., Devane W.A., Colodner S., Doyle S.A., Mechoulam R. Synthetic non-psychotropic cannabinoids with potent anti-inflammatory, analgesic, and leukocyte antiadhesion activities. J Med Chem. 35:1992;3135-3141.